Skip to main content

Post-IPO Secondary Pharmaceutical Companies

Explore 2 pharmaceutical startups that raised post-ipo secondary funding. Access verified founder contact information and fundraising data.

Total Companies
2
Total Funding
$10.4M
Avg Funding
$5.2M
Cities
2

Export 2 Post-IPO Secondary Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Chellaston, United Kingdom
$3.6M
raised

Thalia Therapeutics is a drug reformulation company.

Jun 2026
Post-IPO Secondary

Founder Contacts

41,000+ verified contacts

New York, United States
$6.8M
raised

Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients.

May 2026
Post-IPO Secondary

Founder Contacts

41,000+ verified contacts

Ready to Connect with Post-IPO Secondary Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 2 post-ipo secondary pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked